Stock Screener App

Frei -

Installieren

1.67

4.57% -0.08

after-market

Handel nachbörslich: 1.72 0.05 +2.99%

Acrivon Therapeutics Inc (ACRV)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	19.69	-	21.66	24.95	25.14
Operating Income/Loss	-19.69	-	-21.66	-24.95	-25.14
Nonoperating Income/Loss	1.453	-	1.982	2.123	2.699
Income/Loss From Continuing Operations Before Tax	13.20% -18.23	-21.01	-19.68	-22.83	-22.44
Income/Loss From Continuing Operations After Tax	13.20% -18.23	-21.01	-19.68	-22.83	-22.44
Net Income/Loss	13.20% -18.23	-21.01	-19.68	-22.83	-22.44
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	38.56	-	38.35	1.4944	38.11
Diluted Average Shares	38.56	-	38.35	1.4944	38.11
Basic Earnings Per Share	-0.47	-	-0.51	-0.59	-0.59
Diluted Earnings Per Share	-0.47	-	-0.51	-0.59	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$29.66

0.98%

BNTX

$92.25

0.12%

INSM

$108.87

2.48%

RPRX

$53.86

1.17%

ONC

$302.44

2.52%

RVMD

$154.89

2.20%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters